Coronavirus Latest News

UK approves second Covid vaccine targeting Omicron variant

Pfizer/BioNTech ‘bivalent’ booster, targeting original and Omicron variants, approved along with Moderna jab

A second “bivalent” coronavirus vaccine has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for individuals aged 12 and over.

The regulator confirmed on Saturday that Pfizer/BioNTech’s vaccine had met its standards of safety, quality and effectiveness and had been approved for the UK autumn booster programme.

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button